← Open Payments lookup

ERIN FEENEY: Open Payments

NPI 1053902999 · CAIRO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,468 in 82 payments from 20 companies in 2025. Trend: 2023 $2,588 · 2024 $2,688 · 2025 $1,468

Food & beverage: $1,468
CompanyPaymentsAmount
ABBVIE INC.18$221
GlaxoSmithKline, LLC.11$210
Lilly USA, LLC6$196
PFIZER INC.14$148
Bayer Healthcare Pharmaceuticals Inc.7$122
Novo Nordisk Inc5$114
Janssen Pharmaceuticals, Inc3$84
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$61
AstraZeneca Pharmaceuticals LP3$60
Takeda Pharmaceuticals U.S.A., Inc.2$33

Products named: TRELEGY ELLIPTA, ZEPBOUND, NURTEC ODT, Kerendia, Wegovy, VRAYLAR, SPRAVATO, XIFAXAN.

Industry payments across NY — which companies pay providers there.